Asthma  >>  Alvesco (ciclesonide)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center
NCT00174746: Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma

Completed
2
1145
US
AVE2635A
Sanofi
Asthma
11/05
11/05
NCT00314509 / 2004-004708-19: Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)

Completed
2
240
Europe, RoW
Ciclesonide/Formoterol Combination
AstraZeneca
Asthma
01/06
01/06
NCT00961155: Usefulness of Exhaled Breath Condensate for Evaluation of Markers of Airway Inflammation in Children With Asthma

Unknown status
2
200
Europe
cyklezonid, Alvesco, montelukast sodium, placebo, formoterol 12 mcg twice daily, Formoterol
Medical University of Lodz
Asthma
12/13
06/14
2004-001838-16: Efficacy and safety of a fixed combination of ciclesonide and formoterol once or twice daily in the treatment of persistent asthma A randomized, double-blind, placebo-controlled, parallel-group, multi-center study

Ongoing
2
100
Europe
Ciclesonide/Formoterol Fixed Combination, Ciclesonide-Mono DPI, BY9010,
ALTANA Pharma AG
asthma bronchiale
 
 
2004-002983-80: Comparison of the Efficacy of a Fixed Combination of Ciclesonide and Formoterol versus a Fixed Combination of Fluticasone and Salmeterol

Completed
2
75
Europe
Ciclesonide - Formoterol Fumarate Dry Powder Inhaler, Atmadisc Diskus, BY9010, Atmadisc Diskus, Atmadisc Diskus
ALTANA Pharma AG
asthma bronchiale
 
07/05

Download Options